» Articles » PMID: 9696005

Liver Transplantation for Adult Polycystic Liver Disease

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1998 Aug 8
PMID 9696005
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic liver disease, commonly associated with polycystic kidney disease, can result in massive hepatomegaly and debilitating symptoms. Surgical intervention for symptomatic polycystic liver disease has been associated with significant morbidity and inconsistent long-term palliation; it is more appropriate in patients with a single dominant cyst or cysts which is/are confined to one lobe. At our institution, nine patients have undergone orthotopic liver transplantation for symptomatic hepatic cysts with excellent long-term results and minimal morbidity and mortality. Surgical candidates were selected based on severe limitations in daily activities and on sequelae of hepatic cystic involvement. Other factors considered were the extent and pattern of hepatic cystic disease, the degree of hepatic and renal dysfunction, and prior surgical intervention. Three patients (33%) required combined liver and kidney transplantation because of renal cystic involvement with renal insufficiency. The one-year survival rate was 89% with excellent symptomatic relief and improved quality of life in all the surviving patients. One death occurred in a significantly malnourished 62-year-old female. Complications included one case each of hepatic artery thrombosis requiring retransplantation, biliary leak necessitating biliary reconstruction, and postoperative bleeding requiring re-exploration. The mean hospital stay was 23 days and the mean intraoperative blood transfusion requirement was 18 units. Our experience demonstrates that appropriately selected patients with extensive hepatic involvement with adult polycystic liver disease can have an excellent outcome with transplantation, with morbidity comparable with other surgical options.

Citing Articles

Liver transplant recipients with polycystic liver disease have longer waiting times but better long-term clinical outcomes than those with liver disease due to other causes: A retrospective cross-sectional study.

Gittus M, Moore J, Ong A PLoS One. 2024; 19(1):e0294717.

PMID: 38165905 PMC: 10760649. DOI: 10.1371/journal.pone.0294717.


Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Norcia L, Watanabe E, Hamamoto Filho P, Hasimoto C, Pelafsky L, de Oliveira W Hepat Med. 2022; 14:135-161.

PMID: 36200122 PMC: 9528914. DOI: 10.2147/HMER.S377530.


Long-term results of liver transplantation for polycystic liver disease: Single-center experience in China.

Ding F, Tang H, Zhao H, Feng X, Yang Y, Chen G Exp Ther Med. 2019; 17(5):4183-4189.

PMID: 31007749 PMC: 6468458. DOI: 10.3892/etm.2019.7449.


Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.

Rajoriya N, Tripathi D, Leithead J, Gunson B, Lord S, Ferguson J World J Gastroenterol. 2016; 22(45):9966-9973.

PMID: 28018103 PMC: 5143763. DOI: 10.3748/wjg.v22.i45.9966.


Combined liver and kidney transplant in a patient with budd-Chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up.

De la Piscina P, Duca I, Estrada S, Calderon R, Ganchegui I, Campos A Case Rep Gastrointest Med. 2014; 2014:585291.

PMID: 24987537 PMC: 4058590. DOI: 10.1155/2014/585291.